Groupama Asset Managment Acquires 7,658 Shares of CME Group Inc. $CME

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Groupama Asset Managment increased its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 5.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 143,119 shares of the financial services provider's stock after acquiring an additional 7,658 shares during the quarter. Groupama Asset Managment's holdings in CME Group were worth $37,529,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of CME. Heartland Bank & Trust Co bought a new position in shares of CME Group during the first quarter worth approximately $377,000. Catalyst Capital Advisors LLC grew its position in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock worth $971,000 after buying an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. acquired a new stake in CME Group during the first quarter worth approximately $367,000. Fulcrum Equity Management bought a new position in CME Group during the 1st quarter worth $258,000. Finally, AIA Group Ltd raised its holdings in CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock valued at $4,416,000 after acquiring an additional 2,510 shares in the last quarter. Institutional investors own 87.75% of the company's stock.

Insider Buying and Selling

In related news, Director William R. Shepard bought 256 shares of the firm's stock in a transaction on Wednesday, June 25th. The shares were purchased at an average price of $270.53 per share, with a total value of $69,255.68. Following the completion of the purchase, the director owned 258,196 shares in the company, valued at $69,849,763.88. This represents a 0.10% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Charles P. Carey sold 500 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the transaction, the director owned 4,900 shares of the company's stock, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.30% of the company's stock.

Analyst Ratings Changes

CME has been the subject of a number of recent analyst reports. UBS Group reiterated a "neutral" rating and set a $305.00 target price on shares of CME Group in a research report on Thursday, July 24th. Citigroup upped their price objective on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Barclays set a $298.00 price objective on shares of CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Finally, Piper Sandler upped their price target on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Four analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $261.93.

CME Group Price Performance

NASDAQ:CME traded down $3.80 during trading hours on Friday, hitting $269.52. The company's stock had a trading volume of 1,591,589 shares, compared to its average volume of 1,923,555. CME Group Inc. has a twelve month low of $206.44 and a twelve month high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a fifty day simple moving average of $275.82 and a 200-day simple moving average of $268.50. The company has a market capitalization of $97.13 billion, a P/E ratio of 26.09, a PEG ratio of 4.88 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same quarter in the prior year, the business earned $2.56 earnings per share. The business's revenue for the quarter was up 10.4% compared to the same quarter last year. On average, analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group's dividend payout ratio is presently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.